Structure-Based Discovery and Development of a Series of Potent and Selective Bromodomain and Extra-Terminal Protein Inhibitors-Reference-Cited by-同舟云学术

Structure-Based Discovery and Development of a Series of Potent and Selective Bromodomain and Extra-Terminal Protein Inhibitors

Published:2019-09-06 Issue:18 Volume:62 Page:8642-8663
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Hu Jianping¹,Tian Chang-Qing¹,Damaneh Mohammadali Soleimani¹,Li Yanlian,Cao Danyan,Lv Kaikai¹,Yu Ting,Meng Tao,Chen Danqi,Wang Xin,Chen Lin,Li Jian,Song Shan-Shan,Huan Xia-Juan,Qin Lihuai²,Shen Jingkang,Wang Ying-Qing¹,Miao Ze-Hong¹,Xiong Bing¹^ORCID

Affiliation:

1. University of Chinese Academy of Sciences, NO.19A Yuquan Road, Beijing 100049, China

2. Center for Chemical Biology and Drug Discovery, Department of Pharmacological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b01094

Reference50 articles.

1. Epigenetic protein families: a new frontier for drug discovery

2. BET domain co-regulators in obesity, inflammation and cancer